Acquired by New Relic.
Spica Therapeutics is pioneering Macrophage-Subset targeted therapies
MRM Health is developing a novel type of therapeutics based on beneficial intestinal bacteria.
Trince developed a new transfection technology based on a combination of laser light and photothermal nanoparticles.
